ImQuest CRO HIV Preclinical antiviral anticancer

Contract Research and Development Services

ImQuest BioSciences is a preclinical contract research organization (CRO) that provides expert services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases. These research and discovery and IND-enabling services include comprehensive compound screening to define compound efficacy and drug target validation to define the mechanism of action and toxicity of pharmaceutical products. We provide services for a wide variety of experimental test articles, including small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines.

Preclinical Service Programs

We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. With decades of experience in preclinical contract research we understand that each product and each client is unique and we strive to provide effective solutions to your most complicated needs.

Contract Research testing of Antiviral, Antimicrobial and Anticancer agents coupled with in vitro toxicology analysis
Learn More about the ImQuest Success Platform

Looking for Coronavirus antiviral testing? Please contact us and click here for additional information.